Verona Pharma (VRNA) PT Lowered to $18 at Canaccord Genuity
Tweet
Share
E-mailGet Alerts VRNA Hot Sheet
Price: $15.59 --0%
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 4 | New: 4
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 4 | New: 4
Join SI Premium – FREE
Canaccord Genuity analyst Edward Nash lowered the price target on Verona Pharma (NASDAQ: VRNA) to $18.00 (from $19.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades Sirius XM Radio (SIRI) to Neutral, 'risk-reward is balanced at prevailing levels'
- MSCI Inc. (MSCI) PT Lowered to $615 at Morgan Stanley
- Mattel Inc. (MAT) PT Raised to $27 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
